RE: Cw2522 Jul 2020 14:02
Not commenting on the company as a whole Nolupus - rather that I think a lot of hot money has floated in there after the SNG rise - and I don't think SNG doing well is a good thing for them (as a competitor with a system to get the drug to the lungs that's not only potentially more effective/safer due to localised delivery, no need for painful injections, no need for hospital visits, hospital staff to administer, can maintain isolation, etc).
So their others things may do well, but short term, I think it's a bit of an unwarranted spike.